R
Rachelle Lanciano
Researcher at Memorial Hospital of South Bend
Publications - 6
Citations - 1235
Rachelle Lanciano is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: Cervical cancer & Chemoradiotherapy. The author has an hindex of 5, co-authored 6 publications receiving 1099 citations.
Papers
More filters
Journal ArticleDOI
Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
Claire L Vale,Jayne F. Tierney,Lesley A. Stewart,Mark F. Brady,Ketayun A. Dinshaw,Anders Jakobsen,Mahesh K. B. Parmar,Gillian Thomas,Ted Trimble,David S. Alberts,Hongwei Chen,Slobodan Cikaric,Patricia J. Eifel,Melahat Garipagaoglu,Henry M. Keys,Nermina Kantardzic,Punita Lal,Rachelle Lanciano,Felix Leborgne,Vicharn Lorvidhaya,Hiroshi Onishi,Robert Pearcey,E Pras,Kenneth B. Roberts,Peter G. Rose,Charles W. Whitney +25 more
TL;DR: These results endorse the recommendations of the NCI alert, but also demonstrate their applicability to all women and a benefit of non-platinum-based chemoradiotherapy.
Journal Article
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis
David S. Alberts,Mark F. Brady,S Cikaric,H Chen,Ketayun A. Dinshaw,Patricia J. Eifel,M Garipagaoglu,Anders Jakobsen,N Kantardzic,Henry M. Keys,Punita Lal,Rachelle Lanciano,F Leborgne,Lorvidhaya,H Onishi,M. K. B. Parmar,Robert Pearcey,E Pras,Kenneth B. Roberts,Peter G. Rose,Lesley A. Stewart,Jayne F. Tierney,Gillian Thomas,Ted Trimble,Claire L Vale,Charles W. Whitney +25 more
TL;DR: A meta-analysis seeking updated individual patient data (IPD) from all randomised controlled trials (RCTs) to assess the effect of chemoradiotherapy on all outcomes endorsed the recommendations of the NCI alert, but also demonstrated their applicability to all women and a benefit of non-platinum based cheMoradiotherapy.
Journal ArticleDOI
Randomized Comparison of Weekly Cisplatin or Protracted Venous Infusion of Fluorouracil in Combination With Pelvic Radiation in Advanced Cervix Cancer: A Gynecologic Oncology Group Study
Rachelle Lanciano,Alison R. Calkins,Brian N. Bundy,Groesbeck P. Parham,Joseph A. Lucci,David H. Moore,Bradley J. Monk,Dennis M. O’Connor +7 more
TL;DR: In this study, PVI FU does not show improved outcome over weekly cisplatin, and future research should explore combinations of FU with cisPlatin, new radiosensitizers, and active drugs combined with RT to reduce the high rate of pelvic and distant treatment failure still seen in advanced cervix cancer.
Journal Article
Morbidity after intraperitoneal insertion of saline-filled tissue expanders for small bowel exclusion from radiotherapy treatment fields: a prospective four year experience with 34 patients.
John P. Hoffman,Rachelle Lanciano,N Z Carp,Merrick Ma,Rosenblum Ng,Hogan Wm,Elin R. Sigurdson,Litwin S,Burton L. Eisenberg +8 more
TL;DR: Intraperitoneal placement of a saline-filled tissue expander is a simple, safe and effective means of small bowel exclusion from RT portals, and there were no clinical infections involving the prostheses.
Journal ArticleDOI
Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
Benjamin Movsas,H. Diratzouian,Alexandra L. Hanlon,Harry S. Cooper,Gary M. Freedman,Andre Konski,Elin R. Sigurdson,John P. Hoffman,Neal J. Meropol,Louis M. Weiner,Lawrence R. Coia,Rachelle Lanciano,Joanne Stein,Debra Kister,Burton L. Eisenberg +14 more
TL;DR: This regimen of high dose preoperative chemoRT with a Hfx RT boost (to 61.8 Gy) in patients with bulky, locally advanced rectal cancer results in clinical downstaging in half of the patients with significant fibrosis in the operative specimen.